Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Diabetes Control and Complications Trial (DCCT)

ClinicalTrials.gov ID: NCT00360815

Public ClinicalTrials.gov record NCT00360815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Background. Long-term microvascular and neurologic complications cause major morbidity and mortality in patients with insulin-dependent diabetes mellitus (IDDM). We examined whether intensive treatment with the goal of maintaining blood glucose concentrations close to the normal range could decrease the frequency and severity of these complications. Methods. A total of 1441 patients with IDDM -- 726 with no retinopathy at base line (the primary-prevention cohort) and 715 with mild retinopathy (the secondary-intervention cohort) were randomly assigned to intensive therapy administered either with an external insulin pump or by three or more daily insulin injections and guided by frequent blood glucose monitoring or to conventional therapy with one or two daily insulin injections. The patients were followed for a mean of 6.5 years, and the appearance and progression of retinopathy and other complications were assessed regularly.

Study identification

NCT ID
NCT00360815
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
1,441 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
13 Years to 39 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1983 (Type not available)
Primary completion
Not listed
Completion
Apr 1993 (Type not available)
Last update posted
Mar 2, 2010

1983 – 1993

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of California La Jolla California 92093-0620 —
Yale University School of Medicine New Haven Connecticut 06510 —
University of South Florida College of Medicine Tampa Florida 33612 —
Northwestern University Chicago Illinois 60611 —
DCCT Central Autonomic Coding Unit Springfield Illinois 62702 —
University of Iowa Iowa City Iowa 52242 —
University of Maryland Baltimore Maryland 21201 —
George Washington University, Biostatistics Center Rockville Maryland 20852 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Joslin Diabetes Center, Inc. Boston Massachusetts 02215 —
University of Michigan, Sattelite-Henry Ford Hospital Ann Arbor Michigan 48109-0832 —
Henry Ford Hospital Detroit Michigan 48202 —
International Diabetes Center Minneapolis Minnesota 55416 —
DCCT Central Nutrition Coding Unit Minneapolis Minnesota 55454-1015 —
DCCT Central ECG Reading Unit Minneapolis Minnesota 55455-1015 —
DCCT Central Biochemistry Laboratory Minneapolis Minnesota 55455-9980 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Foundation Rochester Minnesota 55905 —
Backup DCCT Central HbA1c Lab Columbia Missouri 65201 —
University of Missouri Columbia Missouri 65212 —
Washington University at St. Louis St Louis Missouri 63110 —
University of New Mexico School of Medicine Albuquerque New Mexico 87131 —
Cornell University Medical College, The New York Hospital New York New York 10021 —
Albert Einstein College of Medicine The Bronx New York 10461 —
Case Western Reserve University, Lakeside Hospital Cleveland Ohio 44106 —
University of Pennsylvania, The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
University of Pittsburgh, Children's Hospital Pittsburgh Pennsylvania 15213-3417 —
DCCT Central Neurobehavioral Coding Unit Pittsburgh Pennsylvania 15213 —
Medical University of South Carolina Charleston South Carolina 29403-5851 —
University of Tennessee Memphis Tennessee 38163 —
Vanderbilt University, Diabetes Research and Training Center Nashville Tennessee 37212 —
Vanderbilt University Nashville Tennessee 37232-2230 —
University of Texas Dallas Texas 75235 —
University of Washington Seattle Washington 98195 —
DCCT Central Ophthalmologic Reading Unit, Fundus Photo Reading Center Madison Wisconsin 53705-0240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00360815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2010 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00360815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →